Navigation Links
Pee Dee Cardiology Selects Allscripts Professional Electronic Health Record and Practice Management Solution
Date:2/19/2009

lscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company's software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS
'/>"/>

SOURCE Allscripts
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. SCAI and ACC announce new interventional cardiology meeting
2. Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System
3. American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement
4. SCAI Announces New Program to Support Interventional Cardiology Training Fellowships
5. Springer to publish new society journal in cardiology
6. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
7. Orqis(R) Medicals MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting
8. CardiacQA Surpasses 20,000 Client Generated Nuclear Cardiology Reports
9. Medical Simulation Corporation to Present Comprehensive Cardiac Patient Scenario at the Society for Cardiovascular Angiography and Interventions (SCAI) and American College of Cardiology (ACC) Conference
10. Emageon Receives Best in KLAS Cardiology PACS Award
11. Siemens Demonstrates New Version of Multimodality Cardiology Image Management Solution at ACC 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Horizon NJ Health, New Jersey’s largest ... it has earned a Commendable Accreditation status from ... Health is a wholly owned subsidiary of Horizon Blue ... Health Plan Accreditation is a nationally recognized program that ... plans provide to their members. Health Plan Accreditation performance ...
(Date:5/20/2013)... Science is proud to announce the publication of the ... Robert A. Weinberg. , The First Edition has ... incorporating the most important advances in the fast-growing field ... maintains all of its hallmark features admired by students, ... Biology of Cancer is a textbook for students studying ...
(Date:5/20/2013)... (HealthDay News) -- Although many hospital intensive care ... to help improve outcomes, new research suggests this ... Since one-third of teaching hospitals in the United ... a nighttime physician in the ICU, the practice ... away from hospitals with fewer resources, the study ...
(Date:5/20/2013)... departments play a growing role in the U.S. health ... admissions and serving increasingly as an advanced diagnostic center ... Corporation study. , While often targeted as the most ... an important safety net for Americans who cannot get ... the growth of health care costs, according to the ...
(Date:5/20/2013)... Nearly three out of four pregnant women experience ... a Loyola University Medical Center study has found. , ... pregnant women,s quality of life, the study found. , ... Payton Johnson was presented during the American Congress of ... Orleans. , One hundred and four pregnant women were ...
Breaking Medicine News(10 mins):Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 2Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 3Health News:'The Biology of Cancer' by Robert A. Weinberg 2Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:72 percent of pregnant women experience constipation and other bowel problems 2
... being issued by Foundation for Taxpayer and Consumer Rights:, ... against proposed legislation that,would create a loophole in existing ... a patient,s consent. The bill, SB 1096,(Calderon), does so ... to provide health care services. Transfers of private medical,information ...
... PLYMOUTH MEETING, Pa., March 12 Four,Rivers Software ... (CMMS) for the healthcare industry and ECRI Institute,an ... improving,patient care, announce the availability of new, real-time ... alert applications., This new integration offers ...
... 12 Managed Health Care,Associates, Inc. (MHA) announces ... Member Study, the results of which will be,revealed ... 2008 in Las Vegas,Nevada., The report was ... 2007,and examined self-reported data for key operational elements ...
... , Researchers from EPFL and Caltech have made an ... The research, appearing in the March 12 issue of ... kinds of risk, notably financial risk, are often underestimated, and ... drugs) could be caused by an erroneous evaluation of risk. ...
... Hospital today announced the start of the EASE (Exhale ... trial to explore an investigational treatment that may offer ... emphysema. The study focuses on a new procedure, called ... for trapped air (one of the primary causes of ...
... of,positive tests for methamphetamine among U.S. job applicants and ... percent between 2006 and,2007. These findings, from the Quest ... trend in use of the drug by more than ... today by Quest,Diagnostics Incorporated (NYSE: DGX ), the ...
Cached Medicine News:Health News:Four Rivers Software Systems and ECRI Institute Announce New, Real-Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall Tracking 2Health News:Four Rivers Software Systems and ECRI Institute Announce New, Real-Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall Tracking 3Health News:MHA to Release Findings of Independent Long Term Care Member Study 2Health News:To bet or not to bet: How the brain learns to estimate risk 2Health News:Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers 2Health News:Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics 2Health News:Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics 3Health News:Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics 4
(Date:5/17/2013)...  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... UBS Global Healthcare Conference in New York ... at 11 a.m. Eastern Time. To listen to the ... the Investor Relations section of the Company,s Web site at ... days after the event. About Orexigen® Therapeutics ...
(Date:5/17/2013)... 2013   Shareholder rights attorneys  at Robbins Arroyo ... (NASDAQGS: AVEO) securities has filed a complaint in the ... Massachusetts .  The complaint alleges that Aveo and ... of 1934 (the "Exchange Act") between January 3, 2012 ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) Aveo ...
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony ... new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be ... 2013, which will be held at the ... San Diego, California , from May 20 - ... Sony,s second analytical system, incorporating commercial audio-visual technologies into ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... with the National Institute of Allergy and ... biodefense,research, under which the NIAID will conduct ... as a treatment for,anthrax and other high-priority ...
... Double-Blind Study Targets Biomarker-Defined Population, BERKELEY ... GNTA ) announced that the first ... Phase 3 trial of Genasense,(oblimersen sodium) Injection ... is a randomized, double-blind, placebo-controlled study in ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 2Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 3Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: